Join Growin Stock Community!
Back to LLY.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

contract-liabilities-chart

LLY Current Contract Liabilities

Current Contract Liabilities

Browsing restrictions can be lifted for a fee.

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of the most recent data point on 2024-06-30, Eli Lilly (LLY) reports current contract liabilities at 0 USD, following a similar value of 0 USD for the previous quarter. The last significant value was recorded on 2023-12-31, reaching 14.5B USD. From Q1'23 to Q4'23, current contract liabilities showed a sharp increase, rising from 0 USD in Q1'23 to 1.2B USD in Q2'23, 2B USD in Q3'23, and peaking at 14.5B USD in Q4'23. However, starting from Q1'24, the liabilities dropped abruptly to 0 USD and have remained at that level through the latest available data. This pattern suggests a one-time surge in contract liabilities at the end of 2023, followed by a complete reversal in 2024, indicating either a major contract fulfillment or a significant change in reporting or business operations.